City

Ann Arbor (1)

Condition

Hemophagocytic Syndrome (HPS) (1)

Overall Status

Completed (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

University of Michigan Rogel Cancer Center (1)

Collaborator

Intervention

ruxolitinib (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Other (1)

Study Type

Interventional (1)

hemophagocytic syndrome (hps)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hemophagocytic Syndrome (HPS) Trial in Ann Arbor (Ruxolitinib)

Completed

Hemophagocytic Syndrome (HPS)

Ruxolitinib

Ann Arbor, Michigan

University of Michigan Comprehensive Cancer Center

Jan 4, 2021